Cboe - Market News Story

FDA Accepts For Priority Review Bristol-Myers Squibb's Application For Opdivo Plus Yervoy In First-Line Non-Small Cell Lung Cancer

Benzinga Newsdesk      1/15/2020 6:06:35 AM